| Name | Title | Contact Details |
|---|
Partnet is a trusted software and technology leader for the US Government. With over 20 years of experience , Partnet is the company our customers turn to time and again. As the leading provider of comprehensive, flexible, and targeted IT solutions, ...
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Act! is a customer relationship management software application designed for the manufacturing industry.
Spaceti is a proptech startup that offers a SaaS platform to safely and efficiently manage spaces from individual offices to entire campuses. Their Workplace Analytics suite collects data from proprietary or third party sensors, with indoor air quality...
SocialChorus is the leading workforce communications platform that transforms how workers and organizations connect every day. With SocialChorus, organizations are able to connect and align their teams, power organizational initiatives and measure the business outcomes.